165 related articles for article (PubMed ID: 32358358)
1. Loco-regional outcomes of adjusted breast radiotherapy with conventional fractionation after breast conserving surgery: De-escalation of whole breast irradiation dose.
Kim SW; Chun M; Oh YT; Noh OK
Medicine (Baltimore); 2020 May; 99(18):e19916. PubMed ID: 32358358
[TBL] [Abstract][Full Text] [Related]
2. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.
Orecchia R; Veronesi U; Maisonneuve P; Galimberti VE; Lazzari R; Veronesi P; Jereczek-Fossa BA; Cattani F; Sangalli C; Luini A; Caldarella P; Venturino M; Sances D; Zurrida S; Viale G; Leonardi MC; Intra M
Lancet Oncol; 2021 May; 22(5):597-608. PubMed ID: 33845035
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
6. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
[TBL] [Abstract][Full Text] [Related]
7. Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
Reshko LB; Pan J; Rai SN; Ajkay N; Dragun A; Roberts TL; Riley EC; Quillo AR; Scoggins CR; McMasters KM; Eldredge-Hindy H
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):56-65. PubMed ID: 34710520
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
9. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH; Link EK; Kunkler IH; Whelan TJ; Westenberg AH; Gruber G; Bryant G; Ahern V; Purohit K; Graham PH; Akra M; McArdle O; O'Brien P; Harvey JA; Kirkove C; Maduro JH; Campbell ID; Delaney GP; Martin JD; Vu TTT; Muanza TM; Neal A; Olivotto IA;
Lancet; 2022 Aug; 400(10350):431-440. PubMed ID: 35934006
[TBL] [Abstract][Full Text] [Related]
10. Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Coles CE; Haviland JS; Kirby AM; Griffin CL; Sydenham MA; Titley JC; Bhattacharya I; Brunt AM; Chan HYC; Donovan EM; Eaton DJ; Emson M; Hopwood P; Jefford ML; Lightowlers SV; Sawyer EJ; Syndikus I; Tsang YM; Twyman NI; Yarnold JR; Bliss JM;
Lancet; 2023 Jun; 401(10394):2124-2137. PubMed ID: 37302395
[TBL] [Abstract][Full Text] [Related]
11. Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.
Pinnarò P; Giordano C; Farneti A; Faiella A; Iaccarino G; Landoni V; Giannarelli D; Vici P; Strigari L; Sanguineti G
J Exp Clin Cancer Res; 2017 Dec; 36(1):191. PubMed ID: 29282078
[TBL] [Abstract][Full Text] [Related]
12. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis.
Stoian R; Erbes T; Zamboglou C; Scholber J; Gainey M; Sachpazidis I; Haehl E; Spohn SKB; Verma V; Krug D; Rühle A; Juhasz-Böss I; Grosu AL; Nicolay NH; Sprave T
Strahlenther Onkol; 2021 Sep; 197(9):812-819. PubMed ID: 33938966
[TBL] [Abstract][Full Text] [Related]
14. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
15. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
16. A propensity score-matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer.
Magnoni F; Corso G; Maisonneuve P; Massari G; Alberti L; Castelnovo G; Leonardi MC; Sacchini V; Galimberti V; Veronesi P
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1085-1093. PubMed ID: 35254519
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials.
Qi WX; Cao L; Xu C; Zhao S; Chen J
Breast; 2020 Feb; 49():165-170. PubMed ID: 31812892
[TBL] [Abstract][Full Text] [Related]
18. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
[TBL] [Abstract][Full Text] [Related]
19. Individualised target volume selection and dose prescription after conservative surgery, mastectomy and reconstruction.
Chua BH
Breast; 2019 Nov; 48 Suppl 1():S69-S75. PubMed ID: 31839165
[TBL] [Abstract][Full Text] [Related]
20. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]